Stockreport

Vor Bio Announces Proposed Public Offering of $100 Million of Common Stock

Vor Biopharma Inc.  (VOR) 
PDF BOSTON, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Vor Biopharma Inc. (Nasdaq: VOR) (Vor Bio), a clinical-stage biotechnology company dedicated to transforming the treatment of [Read more]